News Grower

Independent coverage of AI, startups, and technology.

Ars Technica May 13, 2026 at 10:00 Big Tech Stable Warm

Could this be the moment that drug manufacturing takes off in orbit?

"I do think it's a really good historical moment for the space industry."

Signal weather

Stable

The story has moved beyond the first headline and now acts as a reliable context anchor.

By Eric Berger Original source
Could this be the moment that drug manufacturing takes off in orbit?

NASA has enabled scientists to study the impact of microgravity on drug development for decades, beginning with the Space Shuttle. This work accelerated in the 2010s, with the completion of the International Space Station and full-time crew members devoted to scientific research. There have been some notable successes during this timeframe, such as the ability to grow a more uniform crystalline form of the cancer drug Keytruda in 2019. This opened up the possibility of administering the drug via injection rather than requiring a patient to spend hours in a clinic setting to receive the drug intravenously. NASA subsidized much of this work, typically paying the considerable costs to transport research to the ISS and for astronaut time to conduct research there. There were, however, trade-offs, such as long lead times to get research into space. Nevertheless, it has become clear that there could be some commercial applications for making drugs in space. Read full article Comments

Stay on the signal

Follow Could this be the moment that drug manufacturing takes off in orbit?

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

This story is still moving and pulling follow-up coverage.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Ars Technica, Drug Manufacturing, and Historical, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

Jun 29, 2026 at 18:21 Ars Technica

Google warns EU's plans to weaken its monopoly could expose user data

The EU wants Google to share search data with competitors and open up AI on Android, but Google alleges major privacy risks.

Jun 29, 2026 at 17:59 Ars Technica

Quantum computing startup says it will leapfrog everybody

But the system would require a massive leap from any of its existing hardware.

Jun 29, 2026 at 17:48 Ars Technica

Kalshi sues Illinois over new tax on prediction market sports bets

Illinois now a key battleground in fight over prediction market sports bets.

Jun 29, 2026 at 16:04 Ars Technica

F1 in Austria: Starts off exciting, then goes the opposite way

A heatwave, engine upgrades, plus power levels for the next two seasons.

Jun 29, 2026 at 15:33 Ars Technica

In a bold move, Rocket Lab acquires Iridium Communications

"We believe this will be one of the most transformative deals in the space industry."

May 13, 2026 at 10:00 Ars Technica

Could this be the moment that drug manufacturing takes off in orbit?

"I do think it's a really good historical moment for the space industry."

How reliable this looks

Signal and trust for Ars Technica

This source works at a steady pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page